New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Psyence Biomedical Ltd.

PBM

Healthcare Biotechnology

2.97 0.11 +3.85%

After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.

Market cap
$10.9M
P/E
0.1×
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
1.2×
Payout ratio
—
Older periods Mar '24 Sep '24 Mar '25 Sep '25
Current Ratio

+8 more quarters

0.09 0.64 11.04 8.09
Net Debt/EBITDA
— 1.70 — 4.78
Debt/Equity
— 0.00 0.00 0.00
Free Cash Flow per Share
0.00 — — —
Book value per Share
— (224.12) — 50.07
Free Cash Flow
(2.95) (1.52) — (2.03)
Other line items

Show all line items

Columns are period end dates